3 Stocks Raising The Health Services Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 77 points (-0.5%) at 16,493 as of Tuesday, Aug. 5, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,020 issues advancing vs. 1,966 declining with 149 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is down 0.6%. A company within the industry that increased today was Fresenius Medical Care AG & Co. KGaA ( FMS), up 2.4%. On the negative front, top decliners within the industry include Ironwood Pharmaceuticals ( IRWD), down 7.6%, Health Net ( HNT), down 3.4%, Grifols ( GRFS), down 2.5%, UnitedHealth Group ( UNH), down 1.4% and Humana ( HUM), down 0.7%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Edwards Lifesciences ( EW) is one of the companies pushing the Health Services industry higher today. As of noon trading, Edwards Lifesciences is up $1.17 (1.2%) to $94.57 on average volume. Thus far, 483,780 shares of Edwards Lifesciences exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $93.20-$94.71 after having opened the day at $93.53 as compared to the previous trading day's close of $93.40.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences has a market cap of $9.7 billion and is part of the health care sector. Shares are up 42.0% year-to-date as of the close of trading on Monday. Currently there are 10 analysts who rate Edwards Lifesciences a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Edwards Lifesciences as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, compelling growth in net income and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Edwards Lifesciences Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, St Jude Medical ( STJ) is up $0.42 (0.6%) to $66.18 on heavy volume. Thus far, 1.3 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $66.01-$66.58 after having opened the day at $66.43 as compared to the previous trading day's close of $65.76.

St. Jude Medical, Inc. develops, manufactures and distributes medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. St Jude Medical has a market cap of $18.6 billion and is part of the health care sector. Shares are up 6.2% year-to-date as of the close of trading on Monday. Currently there are 16 analysts who rate St Jude Medical a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full St Jude Medical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, HCA Holdings ( HCA) is up $1.18 (1.8%) to $67.01 on heavy volume. Thus far, 2.4 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.2 million shares. The stock has ranged in price between $66.10-$67.25 after having opened the day at $66.36 as compared to the previous trading day's close of $65.83.

HCA Holdings, Inc., through its subsidiaries, provides health care services. HCA Holdings has a market cap of $29.1 billion and is part of the health care sector. Shares are up 38.0% year-to-date as of the close of trading on Monday. Currently there are 16 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates HCA Holdings as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full HCA Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%